Background Combating viral hepatitis is part of the UN Sustainable Development Goals
(SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector …

Summary Background The 69th World Health Assembly approved the Global Health Sector
Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis …

Summary Background The 2016 World Health Assembly endorsed the elimination of
hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and …

Summary Background In 2016, the World Health Assembly adopted the resolution to
eliminate viral hepatitis by 2030. This study aims to provide an overview of the burdens of …

Summary Background The 69th World Health Assembly endorsed the global health sector
strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030 …

Background With recent improvements in vaccines and treatments against viral hepatitis, an
improved understanding of the burden of viral hepatitis is needed to inform global …

Estimating the global prevalence of hepatitis B - The Lancet Skip to Main Content
Advertisement The Lancet Journal This Journal Back Journal Home Online First Current Issue …

Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

Background Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in
this paper) are a major cause of morbidity and mortality globally, although the burden and …

Background Despite the existence of effective prevention and treatment interventions,
hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO …